These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 38245792)
21. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study. Yutkin V; Pode D; Pikarsky E; Mandelboim O J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285 [TBL] [Abstract][Full Text] [Related]
22. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells. Igarashi T; Wynberg J; Srinivasan R; Becknell B; McCoy JP; Takahashi Y; Suffredini DA; Linehan WM; Caligiuri MA; Childs RW Blood; 2004 Jul; 104(1):170-7. PubMed ID: 15016654 [TBL] [Abstract][Full Text] [Related]
23. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation. Vacca P; Martini S; Garelli V; Passalacqua G; Moretta L; Mingari MC Eur J Immunol; 2013 Feb; 43(2):550-61. PubMed ID: 23192659 [TBL] [Abstract][Full Text] [Related]
24. Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells. Berg M; Lundqvist A; McCoy P; Samsel L; Fan Y; Tawab A; Childs R Cytotherapy; 2009; 11(3):341-55. PubMed ID: 19308771 [TBL] [Abstract][Full Text] [Related]
25. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma. Cox ST; Danby R; Hernandez D; Laza-Briviesca R; Pearson H; Madrigal JA; Saudemont A Front Immunol; 2018; 9():1282. PubMed ID: 29963042 [TBL] [Abstract][Full Text] [Related]
26. Role of natural-killer group 2 member D ligands and intercellular adhesion molecule 1 in natural killer cell-mediated lysis of murine embryonic stem cells and embryonic stem cell-derived cardiomyocytes. Frenzel LP; Abdullah Z; Kriegeskorte AK; Dieterich R; Lange N; Busch DH; Krönke M; Utermöhlen O; Hescheler J; Sarić T Stem Cells; 2009 Feb; 27(2):307-16. PubMed ID: 18988711 [TBL] [Abstract][Full Text] [Related]
27. Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy. Ayello J; Hochberg J; Flower A; Chu Y; Baxi LV; Quish W; van de Ven C; Cairo MS Exp Hematol; 2017 Feb; 46():38-47. PubMed ID: 27765614 [TBL] [Abstract][Full Text] [Related]
28. TIGIT immune checkpoint blockade enhances immunity of human peripheral blood NK cells against castration-resistant prostate cancer. Wang F; Liu S; Liu F; Xu T; Ma J; Liang J; Wang J; Liu D; Yang F; Li J; Xing N Cancer Lett; 2023 Aug; 568():216300. PubMed ID: 37414394 [TBL] [Abstract][Full Text] [Related]
29. Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions. Wang Z; Guan D; Wang S; Chai LYA; Xu S; Lam KP Front Immunol; 2020; 11():202. PubMed ID: 32153568 [TBL] [Abstract][Full Text] [Related]
30. HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells. Carbone E; Neri P; Mesuraca M; Fulciniti MT; Otsuki T; Pende D; Groh V; Spies T; Pollio G; Cosman D; Catalano L; Tassone P; Rotoli B; Venuta S Blood; 2005 Jan; 105(1):251-8. PubMed ID: 15328155 [TBL] [Abstract][Full Text] [Related]
31. Specific activation of human peripheral blood gamma/delta + lymphocytes by sonicated antigens of Mycobacterium tuberculosis: role in vitro in killing human bladder carcinoma cell lines. Wang MH; Chen YQ; Gercken J; Ernst M; Böhle A; Flad HD; Ulmer AJ Scand J Immunol; 1993 Sep; 38(3):239-46. PubMed ID: 8356400 [TBL] [Abstract][Full Text] [Related]
32. Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2 Chu Y; Nayyar G; Jiang S; Rosenblum JM; Soon-Shiong P; Safrit JT; Lee DA; Cairo MS J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34244307 [TBL] [Abstract][Full Text] [Related]
33. NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation. Wu X; Sharma A; Oldenburg J; Weiher H; Essler M; Skowasch D; Schmidt-Wolf IGH Front Immunol; 2021; 12():731767. PubMed ID: 34691037 [TBL] [Abstract][Full Text] [Related]
34. The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells. Zhu S; Denman CJ; Cobanoglu ZS; Kiany S; Lau CC; Gottschalk SM; Hughes DP; Kleinerman ES; Lee DA Pharm Res; 2015 Mar; 32(3):779-92. PubMed ID: 24203492 [TBL] [Abstract][Full Text] [Related]
35. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells]. Mei JZ; Guo KY; Wei HM; Song CY Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663 [TBL] [Abstract][Full Text] [Related]
36. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104. Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142 [TBL] [Abstract][Full Text] [Related]
37. MICA/IL-12: A novel bifunctional protein for killer cell activation. Tietje A; Yang X; Yu X; Wei Y Oncol Rep; 2017 Mar; 37(3):1889-1895. PubMed ID: 28098874 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility. Shiraishi K; Mimura K; Kua LF; Koh V; Siang LK; Nakajima S; Fujii H; Shabbir A; Yong WP; So J; Takenoshita S; Kono K J Gastroenterol; 2016 Dec; 51(12):1101-1111. PubMed ID: 27002316 [TBL] [Abstract][Full Text] [Related]
39. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA. Kloss M; Decker P; Baltz KM; Baessler T; Jung G; Rammensee HG; Steinle A; Krusch M; Salih HR J Immunol; 2008 Nov; 181(10):6711-9. PubMed ID: 18981088 [TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation. Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G Front Immunol; 2020; 11():1534. PubMed ID: 32849519 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]